Antares Pharma Stock News

May 03, 2020 (CDN Newswire via Comtex) -- A new market research study titled Global Drug Delivery Technology Market 2020 by Company, Regions, Type and...

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

Dublin, May 01, 2020 -- The "Needle Free Drug Delivery Device Market Report: Trends, Forecast, and Competitive Analysis" report has been added to.

Antares Pharma (NASDAQ:ATRS) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Thursday, BidAskClub reports. A number of other equit

EWING, N.J., April 28, 2020 -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first quarter 2020 financial results and recent operating progress before.

Bank of America Corp DE trimmed its holdings in shares of Antares Pharma Inc (NASDAQ:ATRS) by 42.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities a

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics (FLXN) and Dexcom (DXCM) with bullish

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics ( FLXN – Research Report ) and Dexcom ( DXCM – Research Report ) with bullish

Assenagon Asset Management S.A. bought a new stake in Antares Pharma Inc (NASDAQ:ATRS) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commissio

Wall Street brokerages expect Antares Pharma Inc (NASDAQ:ATRS) to announce $30.80 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for Antares Pharma�

Antares Pharma Inc (NASDAQ:ATRS) – Equities researchers at Piper Sandler reduced their FY2020 earnings estimates for Antares Pharma in a research report issued on Monday, April 20th. Piper Sandler a

Emergent BioSolutions Inc. (EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with responsibility for leading and further establishing Emergent’s globa

Bob Apple has been the CEO of Antares Pharma, Inc. (NASDAQ:ATRS) since 2016. First, this article will compare CEO...

Geode Capital Management LLC boosted its holdings in shares of Antares Pharma Inc (NASDAQ:ATRS) by 3.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and